NFT – is non‑invasive brain training that provides users with real‑time neural signals so they can learn to self‑regulate brain activity. Mostly NFT uses the feedback from scalp EEG that uses the millisecond temporal resolution, or fMRI for deeper structures and networks The learning framework of NFT is operant‑conditioning paradigm — contingent reinforcement encourages voluntary modulation of targeted electrophysiological features (power, coherence, BOLD). The core components are: signal acquisition → real‑time processing and feature extraction → contingent feedback loop → repeated training sessions to consolidate change.The main Problem of NFT is the group averages: traditional protocols (alpha, theta/beta, SMR) are based on population norms and may not match an individual's phenotype or symptom profile. So individualized targets should define targets from each patient’s baseline EEG/QEEG signature or subject‑specific fMRI maps to reduce mismatch and increase relevance. Targets should be defined according the symptoms‑ and network‑driven selection. and adaptive dosing: adjust thresholds, reinforcers, and target features across sessions based on in‑session performance and evolving biomarkers to refine training over time.

Neurophysiological mechanisms of NFT action include the alters of band‑specific power, that are functionally linked to attention, arousal, inhibition, and sleep. The mechanism of NFT lies on the synaptic and circuit plasticity: reinforcement learning mechanisms produce persistent changes across sessions, supporting durable electrophysiological shifts. and modifying the large‑scale functional connectivity and cortico‑subcortical loops (e.g., prefrontal–limbic circuits) that underlie cognitive and affective control.QEEG‑Based Assessment and Personalization against normative databases highlights individual deviations in frequency, topography, and connectivity to guide target selection. Combine QEEG biomarkers with detailed clinical history and validated psychometrics to match protocol (site, band, reinforcement strategy) to symptoms and goals. Using the standardized instruments and periodic QEEG to track response and inform adaptation is helpful for predefining the neurophysiological biomarkers and clinical outcome measures.

Clinical Applications of NFT in Psychiatry show the benefits for attention and some neuropsychological measures of ADHD. anxiety and depression. epilepsy (seizure reduction in some protocols), insomnia (sleep‑related bands), PTSD (emotion regulation networks), and substance‑use disorders.Meanwhile there are some evidence caveats such as heterogeneous protocols, variable trial sizes, inconsistent sham controls, and mixed endpoints limit firm conclusions for many conditions; stronger RCTs and biomarker stratification needed. Real‑time fMRI & closed‑loop BCI offer access to deep structures and whole‑network targets, enabling novel emotion and cognitive‑control interventions, but feedback delay for fMRI NFT is too long.

Future NFT developments could include Brain‑computer interfaces because Multi‑site, adaptive control loops and richer feedback modalities improve specificity and user engagement. Beside it automated feature discovery, participant stratification, and adaptive reinforcement scheduling can personalize dosing and optimize trajectories. Combining NFT with noninvasive neuromodulation or pharmacological priming is investigational for augmenting plasticity and accelerating effects does not lead to benefice.Due to methodological heterogeneity, future research is needed to address the wide diversity of objectives, protocols, number of sessions/doses, outcome measures, and analysis algorithms using rigorous placebo/sham methods, and to conduct larger, well-blinded randomized controlled trials.

So, it’s possible to conclude that personalized neurofeedback is a non‑invasive, operant‑conditioning–based intervention that aligns individual neurophysiology (EEG/fMRI) with targeted training to modulate circuits and behavior. The potential of NFT is the advance in real‑time imaging, closed‑loop BCIs, and AI/ML increase specificity, depth, and scalability of interventions. The field needs standardized outcome measures, preregistered sham‑controlled trials, biomarker‑driven stratification, and integrated mechanistic studies to demonstrate efficacy and mechanism.Practical recommendations are: use QEEG + clinical phenotyping to set individualized targets, adopt adaptive algorithms and prespecified biomarkers for monitoring, and prioritize rigorous trial designs for clinical translation.

To be Added